Cargando…

Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection

BACKGROUND: Fecal microbiota transplantation (FMT) has been shown to be safe and effective in treating refractory or relapsing C. difficile infection (CDI), but its use has been limited by practical barriers. We recently reported a small preliminary feasibility study using orally administered frozen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Youngster, Ilan, Mahabamunuge, Jasmin, Systrom, Hannah K., Sauk, Jenny, Khalili, Hamed, Levin, Joanne, Kaplan, Jess L., Hohmann, Elizabeth L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016994/ https://www.ncbi.nlm.nih.gov/pubmed/27609178 http://dx.doi.org/10.1186/s12916-016-0680-9

Ejemplares similares

1798 Oral, Frozen Fecal Microbiota Capsules for Relapsing Clostridium difficile Infection
por: Youngster, Ilan, et al.
Publicado: (2014)

Effectiveness of FMT in recurrent Clostridium difficile infection
por: Grzesiowski, P, et al.
Publicado: (2015)

Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial
por: Yu, Elaine W., et al.
Publicado: (2020)

Case series of successful treatment with fecal microbiota transplant (FMT) oral capsules mixed from multiple donors even in patients previously treated with FMT enemas for recurrent Clostridium difficile infection
por: Chehri, Mahtab, et al.
Publicado: (2018)

Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
por: Fareed, Shaaz, et al.
Publicado: (2018)

1122. Evaluation of Fecal Microbiota Transplant (FMT) in Elderly Patients With recurrent Clostridium difficile Infection (CDI)
por: Hassoun, Ali, et al.
Publicado: (2018)

OR26-06 Fecal Microbiota Transplantation Trial for the Improvement of Metabolism (FMT-TRIM): A Randomized Double-Blind Placebo-Controlled Pilot Trial
por: Yu, Elaine Wei-Yin, et al.
Publicado: (2020)

Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT) vs. FMT Enriched with Lactobacillus in the Treatment of Recurrent Clostridioides difficile Infection
por: Garza-González, Elvira, et al.
Publicado: (2019)

Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017)

Fecal Microbiota Transplantation (FMT) for Recurrent/Refractory Clostridium difficile Infection (CDI) in Pediatric Immunocompromised Patients: A Single-center Experience
por: Kwendakwema, Natasha, et al.
Publicado: (2017)

Long-term taxonomic and functional divergence from donor bacterial strains following fecal microbiota transplantation in immunocompromised patients
por: Moss, Eli L., et al.
Publicado: (2017)

Fecal Microbiota Transplantation by Freeze-Dried Oral Capsules for Recurrent Clostridium difficile Infection
por: Hecker, Michelle T., et al.
Publicado: (2016)

Clinical and Economic Evaluation of commercialized Fecal Microbiota Transplant (cFMT) for Patients with Recurrent Clostridium difficile Infection (CDI) in a Large Community Hospital
por: Hassoun, Ali, et al.
Publicado: (2017)

Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection
por: Tian, Hongliang, et al.
Publicado: (2023)

Step-up fecal microbiota transplantation (FMT) strategy
por: Cui, Bota, et al.
Publicado: (2016)

Monkeypox and fecal microbiota for transplantation(FMT): An unprecedented risk?
por: Owais, Rabia, et al.
Publicado: (2022)

Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection
por: Hirsch, Bruce E, et al.
Publicado: (2015)

Durability and Long-Term Clinical Outcomes of Fecal Microbiota Transplant (FMT) Treatment in Patients with Recurrent C. difficile Infection
por: Mamo, Yafet, et al.
Publicado: (2017)

Fecal Microbiota Transplant in Severe and Non-Severe Clostridioides difficile Infection. Is There a Role of FMT in Primary Severe CDI?
por: Popa, Daniel, et al.
Publicado: (2021)

Fecal Transplantation for the Treatment of Recurrent Clostridium Difficile Infection
por: Karadsheh, Zeid, et al.
Publicado: (2013)

Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
por: Hussam, Dina, et al.
Publicado: (2017)

Fecal Microbiota Transplantation (FMT) as an Adjunctive Therapy for Depression—Case Report
por: Doll, Jessica P. K., et al.
Publicado: (2022)

1211. Response to Fecal Microbiota Transplant (FMT) in Refractory Clostridioides difficile Infection (CDI) is Modest Compared to Recurrent CDI in Hospitalized Patients
por: Shin, Jae Hyun, et al.
Publicado: (2020)

2092 A multicenter study of fecal microbiota transplantation for Clostridium difficile infection in children
por: Nicholson, Maribeth R., et al.
Publicado: (2018)

Comparative Effectiveness of Vancomycin vs. Metronidazole in Mild Clostridium difficile Infections, and Potential Impact on Subsequent Vancomycin-Resistant Enterococcus (VRE) Isolation
por: Youngster, Ilan, et al.
Publicado: (2017)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection
por: Kim, Jieun, et al.
Publicado: (2017)

Patient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection
por: Zellmer, Caroline, et al.
Publicado: (2016)

615. Can We Restore the Lung Microbiome with Fecal Microbiota Transplant (FMT)?
por: Mendez, Roberto, et al.
Publicado: (2018)

rUTI Resolution After FMT for Clostridioides difficile Infection: A Case Report
por: Aira, Andrea, et al.
Publicado: (2020)

1929. Evaluating Disparities in Recurrent Clostridioides difficile Infection (CDI) and Fecal Microbiota Transplant (FMT) Treatment using Geospatial and Social Vulnerability Analytic Tools
por: Little, Keighly, et al.
Publicado: (2023)

Fecal Microbiota Transplantation (FMT) Alleviates Experimental Colitis in Mice by Gut Microbiota Regulation
por: Zhang, Wanying, et al.
Publicado: (2020)

Treatment of relapsing Clostridium difficile infection using fecal microbiota transplantation
por: Pathak, Rahul, et al.
Publicado: (2013)

Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection
por: Seekatz, Anna Maria, et al.
Publicado: (2016)

Fecal Microbiota Transplantation: Expanding Horizons for Clostridium difficile Infections and Beyond
por: Borody, Thomas J., et al.
Publicado: (2015)

Fecal microbiota transplantation for Clostridium difficile infection in patients with ileal pouches
por: Lan, Nan, et al.
Publicado: (2017)

Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease
por: Shouval, Roni, et al.
Publicado: (2019)

Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D
por: Singh, Prashant, et al.
Publicado: (2022)

How to Apply FMT More Effectively, Conveniently and Flexible – A Comparison of FMT Methods
por: Varga, Adorján, et al.
Publicado: (2021)

Is Fecal Leukocyte Test a good predictor of Clostridium difficile associated diarrhea?
por: Reddymasu, Savio, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_a6mgeu4s1bkceem8a9dgitogpp